1. Home
  2. SNCY vs FTRE Comparison

SNCY vs FTRE Comparison

Compare SNCY & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sun Country Airlines Holdings Inc.

SNCY

Sun Country Airlines Holdings Inc.

HOLD

Current Price

$16.17

Market Cap

867.0M

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$13.70

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNCY
FTRE
Founded
1982
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
867.0M
829.3M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
SNCY
FTRE
Price
$16.17
$13.70
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$19.50
$14.06
AVG Volume (30 Days)
600.8K
1.5M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$1,126,769,000.00
$2,723,400,000.00
Revenue This Year
$12.27
N/A
Revenue Next Year
$7.51
$3.09
P/E Ratio
$37.60
N/A
Revenue Growth
4.74
1.00
52 Week Low
$10.14
$3.97
52 Week High
$22.29
$18.67

Technical Indicators

Market Signals
Indicator
SNCY
FTRE
Relative Strength Index (RSI) 45.66 59.11
Support Level $15.36 $8.85
Resistance Level $17.93 $18.26
Average True Range (ATR) 0.65 0.81
MACD 0.05 -0.13
Stochastic Oscillator 49.16 45.44

Price Performance

Historical Comparison
SNCY
FTRE

About SNCY Sun Country Airlines Holdings Inc.

Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: